Therefore, although we cannot exclude the possible involvement of other cellular factors, for example, other Receptor Tyrosine Kinases that are also overexpressed in many cancer cells, our data show that the EGFR-Akt-mTOR pathway is one of the key factors involved in the SMF-induced differential effects in different cell types at different densities. The gene discussed is EGFR; the disease is cancer.